SK66198A3 - Diagnostics for and mediators of inflammatory disorders - Google Patents

Diagnostics for and mediators of inflammatory disorders Download PDF

Info

Publication number
SK66198A3
SK66198A3 SK661-98A SK66198A SK66198A3 SK 66198 A3 SK66198 A3 SK 66198A3 SK 66198 A SK66198 A SK 66198A SK 66198 A3 SK66198 A3 SK 66198A3
Authority
SK
Slovakia
Prior art keywords
antibody
lipid
antigen
primary amine
hydroperoxide
Prior art date
Application number
SK661-98A
Other languages
English (en)
Slovak (sk)
Inventor
Sampath Parthasarathy
Russell M Medford
R Wayne Alexander
Original Assignee
Atherogenics Inc
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atherogenics Inc, Univ Emory filed Critical Atherogenics Inc
Publication of SK66198A3 publication Critical patent/SK66198A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
SK661-98A 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders SK66198A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2640196P 1996-09-20 1996-09-20
US3933397P 1997-03-17 1997-03-17
PCT/US1997/016695 WO1998012561A1 (en) 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders

Publications (1)

Publication Number Publication Date
SK66198A3 true SK66198A3 (en) 1999-09-10

Family

ID=26701197

Family Applications (1)

Application Number Title Priority Date Filing Date
SK661-98A SK66198A3 (en) 1996-09-20 1997-09-19 Diagnostics for and mediators of inflammatory disorders

Country Status (16)

Country Link
US (1) US20020052000A1 (pt)
EP (1) EP0883811A1 (pt)
JP (1) JP2000500879A (pt)
KR (1) KR19990071477A (pt)
AU (1) AU722625B2 (pt)
BG (1) BG102541A (pt)
BR (1) BR9710402A (pt)
CA (1) CA2237191A1 (pt)
CZ (1) CZ146598A3 (pt)
EA (1) EA002520B1 (pt)
HU (1) HUP0102907A1 (pt)
NO (1) NO982265L (pt)
NZ (1) NZ330475A (pt)
PL (1) PL326750A1 (pt)
SK (1) SK66198A3 (pt)
WO (1) WO1998012561A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
CA2348685A1 (en) * 1998-11-06 2000-05-18 Emory University Biomarkers for oxidative stress
US6953666B1 (en) 1998-11-06 2005-10-11 Emory University Biomarkers for oxidative stress
JP4629175B2 (ja) * 1999-12-16 2011-02-09 日油株式会社 モノクローナル抗体
US6495335B2 (en) 2000-12-07 2002-12-17 Mario Chojkier Compositions and methods for diagnosing alzheimer's disease
US20040126767A1 (en) * 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
US20040121350A1 (en) * 2002-12-24 2004-06-24 Biosite Incorporated System and method for identifying a panel of indicators
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
EP1613946A4 (en) * 2003-03-20 2006-07-12 Univ Northeastern Ohio INCLUDED TEST DEVICE FOR FAST DETECTION OF BIOLOGICAL CONTAMINANTS
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
MX2007000208A (es) * 2004-07-01 2007-08-07 Schepens Eye Res Inst Composiciones y metodos para tratar trastornos y condiciones del ojo.
US8129123B2 (en) 2004-10-05 2012-03-06 The Regents Of The University Of California Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
KR101230740B1 (ko) * 2010-09-08 2013-02-07 인제대학교 산학협력단 자간전증의 조기 진단 및 예후 평가 방법
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
PL3311158T3 (pl) 2015-06-19 2023-11-27 Sera Prognostics, Inc. Pary biomarkerów do przewidywania przedwczesnego porodu
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675281A (en) * 1984-07-09 1987-06-23 Lands William E M Quantification of hydroperoxides using prostaglandin H synthase
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
DE69423436T2 (de) * 1993-06-25 2000-09-07 Smithkline Beecham P.L.C., Brentford An lipoprotein gebundene phospholipase a2, inhibitoren davon und deren verwendung für diagnose und therapie
AU1117397A (en) * 1995-10-27 1997-05-15 Board Of Regents Of The University Of Nebraska, The Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease

Also Published As

Publication number Publication date
NZ330475A (en) 1999-11-29
AU4647397A (en) 1998-04-14
EA199800460A1 (ru) 1998-12-24
KR19990071477A (ko) 1999-09-27
CA2237191A1 (en) 1998-03-26
WO1998012561A1 (en) 1998-03-26
HUP0102907A1 (hu) 2004-05-28
BR9710402A (pt) 1999-08-17
PL326750A1 (en) 1998-10-26
JP2000500879A (ja) 2000-01-25
NO982265D0 (no) 1998-05-18
CZ146598A3 (cs) 1998-11-11
NO982265L (no) 1998-07-16
AU722625B2 (en) 2000-08-10
EP0883811A1 (en) 1998-12-16
BG102541A (en) 1999-02-26
EA002520B1 (ru) 2002-06-27
US20020052000A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU722625B2 (en) Diagnostics for and mediators of inflammatory disorders
WO1998012561A9 (en) Diagnostics for and mediators of inflammatory disorders
Afonso et al. Lipoproteins as targets and markers of lipoxidation
US4900662A (en) CK-MM myocardial infarction immunoassay
JP3370334B2 (ja) 酸化リポタンパク質の測定法およびその用途
US6492185B1 (en) Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
US5374533A (en) Method for determining chondrocalcin
WO1993018067A1 (en) Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
AU4465001A (en) Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
WO1987003377A1 (en) Monoclonal antibody against glutathione s-transferase and process for its preparation
US6210906B1 (en) Specific antibodies to kringle 5 of apo(a) and methods of use therefor
JP3499875B2 (ja) 解離性大動脈瘤を検出するための抗体試薬及びその用途
US7160733B2 (en) Ligand specific to β2-glycoprotein I and use thereof
JP4192092B2 (ja) アルコール消費量を検出するための方法および手段
JP3981147B2 (ja) 消化器疾患用抗体試薬
MXPA98003985A (en) Diagnostics for and mediators of inflammatory disorders
GB2241702A (en) Antibodies binding to stratum corneum of the epidermis
JP2949354B2 (ja) 変性リポタンパクの測定法及びこれに用いるキット
JP2878317B2 (ja) ラミニン測定試薬
JPH0690203B2 (ja) 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
JP4054380B2 (ja) 消化器疾患用診断薬
CN1207175A (zh) 炎症疾病的诊断和介体
JPH03197865A (ja) フォスファチジルコリンの測定法
JPH09274042A (ja) ヒトｃｙｐ２ｅ１に対する抗体
JPH0694708A (ja) 抗グルタミン酸デカルボキシラーゼ抗体の検出方法